$ Value
$0
Shares
2,623
Price
$0
Filed
Aug 19
Insider
Name
Geist William
Title
PRESIDENT, PROTEIN SCIENCES
CIK
0001832210
Roles
Transaction Details
Transaction Date
2025-08-15
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
15,915
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. | Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026. | Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. | Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). | Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. | 9,911 restricted stock units vest on 11/1/2025. | Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). | 2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027. | Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. | Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). | 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. | Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
Filing Info
Geist William's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-03 | TECH | M | $0 |
| 2025-11-03 | TECH | F | $283K |
| 2025-11-03 | TECH | M | $0 |
| 2025-08-15 | TECH | M | $0 |
| 2025-08-15 | TECH | F | $43K |
| 2025-08-15 | TECH | M | $0 |
| 2025-08-15 | TECH | A | $0 |
| 2025-08-15 | TECH | A | $0 |
| 2025-08-15 | TECH | A | $0 |
Other Insiders at TECH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kelderman Kim
Chief Executive Officer
|
— | — | 2026-04-14 |
|
McManus Matthew
President - Diag & Spatial Bio
|
— | — | 2026-02-01 |
|
Bohnen Shane
SVP - General Counsel
|
— | — | 2026-04-03 |
| Herr Amy E. | — | $117K | 2026-02-17 |
|
Crouse Steven C.
President - Diag & Spatial Bi
|
— | — | 2026-03-02 |